NCT01284647

A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis

A Prospective, Randomized, Double-blind, Double-dummy, Sucralfate Controlled, Multicenter Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 156 (actual)
• Sponsor: Changhai Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy of teprenone on chronic non-atrophic erosive gastritis and its therapeutic mechanism

Conditions

• Chronic Erosive Gastritis

Interventions

Type	Name	Description
DRUG	Teprenone capsule and placebo of sucralfate	Teprenone 1 capsule (50mg)+placebo of sucralfate 4tab, tid×8 weeks.
DRUG	Sucralfate and placebo of teprenone	Placebo of teprenone 1 capsule+ sucralfate 4 tab(1.0), tid×8 weeks

Timeline

• Start date: 2011-02-01
• Primary completion: 2012-10-01
• Completion: 2013-06-01
• First posted: 2011-01-27
• Last updated: 2014-01-14

Locations

8 sites across 1 country: China